99 related articles for article (PubMed ID: 9422443)
1. Intracavernosal injection therapy: a practical guide.
Mulhall JP
Tech Urol; 1997; 3(3):129-34. PubMed ID: 9422443
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy.
Sexton WJ; Benedict JF; Jarow JP
J Urol; 1998 Mar; 159(3):811-5. PubMed ID: 9474156
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
[TBL] [Abstract][Full Text] [Related]
4. Compliance to longterm vasoactive intracavernous therapy.
Pagliarulo A; Ludovico GM; Cirillo-Marucco E; Corvasce A; Pagliarulo G
Int J Impot Res; 1996 Jun; 8(2):63-4. PubMed ID: 8858392
[TBL] [Abstract][Full Text] [Related]
5. Current status of local penile therapy.
Montorsi F; Salonia A; Zanoni M; Pompa P; Cestari A; Guazzoni G; Barbieri L; Rigatti P
Int J Impot Res; 2002 Feb; 14 Suppl 1():S70-81. PubMed ID: 11850739
[TBL] [Abstract][Full Text] [Related]
6. Intracavernous injection therapy for male erectile dysfunction.
Fallon B
Urol Clin North Am; 1995 Nov; 22(4):833-45. PubMed ID: 7483132
[TBL] [Abstract][Full Text] [Related]
7. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
[TBL] [Abstract][Full Text] [Related]
8. Intracavernosal injection algorithm.
Albaugh JA
Urol Nurs; 2006 Dec; 26(6):449-53. PubMed ID: 17253079
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Raina R; Lakin MM; Thukral M; Agarwal A; Ausmundson S; Montague DK; Klein E; Zippe CD
Int J Impot Res; 2003 Oct; 15(5):318-22. PubMed ID: 14562131
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
[TBL] [Abstract][Full Text] [Related]
11. [Teaching the patient about intra-cavernous injections to prevent erectile dysfunction].
Héron M
Soins; 2007 Mar; (713):50-1. PubMed ID: 17419575
[No Abstract] [Full Text] [Related]
12. [The impact of creating andrology units on the treatment of erectile dysfunction with intracavernosal injections].
Ramada Benlloch FJ; Navalon Verdejo P; Claramonte Ramon FJ; Beltrán Mesenguer JF; Ramos de Campos M; Zaragozá Orts J
Arch Esp Urol; 1999 Apr; 52(3):257-61. PubMed ID: 10371742
[TBL] [Abstract][Full Text] [Related]
13. The causes of patient dropout from penile self-injection therapy for impotence.
Mulhall JP; Jahoda AE; Cairney M; Goldstein B; Leitzes R; Woods J; Payton T; Krane RJ; Goldstein I
J Urol; 1999 Oct; 162(4):1291-4. PubMed ID: 10492182
[TBL] [Abstract][Full Text] [Related]
14. A positive urine opiate screen following intracavernosal papaverine injection.
Pierpaoli SM; Mulhall JP
J Urol; 1998 Apr; 159(4):1299. PubMed ID: 9507861
[No Abstract] [Full Text] [Related]
15. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
[TBL] [Abstract][Full Text] [Related]
16. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
[TBL] [Abstract][Full Text] [Related]
17. Predictors of success and risk factors for attrition in the use of intracavernous injection.
Gupta R; Kirschen J; Barrow RC; Eid JF
J Urol; 1997 May; 157(5):1681-6. PubMed ID: 9112505
[TBL] [Abstract][Full Text] [Related]
18. Evaluating erectile dysfunction: oral sildenafil versus intracavernosal injection of papaverine.
Viswaroop B; B A; Gopalakrishnan G
Natl Med J India; 2005; 18(6):299-301. PubMed ID: 16483029
[TBL] [Abstract][Full Text] [Related]
19. Delineating patient errors in an intracavernosal injection program.
Furtado TP; Teloken PE; Ortega Y; Narus J; Wolchasty NP; Mulhall JP
J Sex Med; 2024 May; 21(6):529-532. PubMed ID: 38660738
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with intracavernous auto-injection for the treatment of erection disorders].
van Deventer CP; Meuleman EJ; Bierkens PB; Sabbe BG; Smals AG
Ned Tijdschr Geneeskd; 1993 Feb; 137(8):408-12. PubMed ID: 8446199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
